Video

Transcript:

Disease modeling can be a powerful research tool to support evidence-based patient centric pharmaceutical development strategies. 

The disease modeling process involves working with stakeholders to develop a conceptual and a quantitative understanding of the disease and how new treatments might make a difference. Early in development, this brings together clinical, market access, and commercial teams to align on key value drivers and evidence plans. 

Transcript: 

It's been fantastic being here at ISPOR Glasgow this year. As a Medical Affairs Specialist, I was fascinated to see how colleagues, health economists, modulars, statisticians, policy experts, all of us have a different way, a nuanced way, of defining what value is. But at the end of the day, all of us are speaking the same language. 

How best to showcase patient voice and patient opinion across decision making processes and across the healthcare industry.

JCA has raised expectations for evidence planning and assessment across Europe. But generating evidence is only part of the challenge. Manufacturers must also understand how therapies will be implemented, adopted, and communicated. 

Discover how an integrated approach can help teams: 

Transcript:
Multiple sclerosis, or MS, is a progressive, disabling neurological disease associated with a significant humanistic and economic burden. While there is no cure for MS, disease-modifying therapies have been shown to have an impact on MS-related disability and relapses.  

Intelligence have significantly impacted research, promising new efficiencies and insights that accelerate discovery. While this technology holds great promise, it also comes with risk. We help clients understand how to effectively use AI in a rapidly changing landscape.

At RTI Health Solutions, we prioritize responsible AI use by adhering to 5 key principles.

Joint Clinical Assessments (JCAs) are now live and will apply to orphan medicines starting in 2028. We’d like to take you through 5 steps to success and share some of what we’ve learned from working on JCA submissions.

Transcript:

I joined RTI Health Solutions to lead the development of our Implementation Science practice. We're tackling one of the biggest challenges in the pharmaceutical industry: ensuring that groundbreaking therapies are not only approved but also successfully integrated into real-world healthcare systems.

Transcript: